Health
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 – StreetInsider.com
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ –Â AbbVie (NYSE: ABBV) today announced the presentation of new data on…
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab) across multiple rheumatic diseases at the American College…
Continue Reading
-
General13 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Noosa News5 hours agoWhy the Brisbane City Hall clock has fallen silent
-
Noosa News17 hours agoNew One Nation branch | Noosa Today
-
Noosa News7 hours agoFederal government to review trade restrictions for Philippine banana imports